Search Results
Results found for "Michel Bouvier"
- Michel Bouvier appointed Knight of the Ordre national du Québec
June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC
- GPCR Therapeutics Expands Scientific Advisory Board
Michel Bouvier, Dr. Luisa Salter-Cid, Dr. Omar Nadeem and Dr.
- 📰 GPCR Weekly News, March 4 to 10, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi, Simone Prömel and Michel Bouvier
- Exploring the Breakthroughs in GPCR Research
Badr Sokrat, Michel Bouvier, et al. for their study on the Role of the V2R-βarrestin-Gβγ complex in promoting
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Michel Bouvier, J Silvio Gutkind, and team found that Gαs is essential for GRK selectivity and gene regulation
- 📰 GPCR Weekly News, February 26 to March 3, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi, Simone Prömel and Michel Bouvier
- 📰 GPCR Weekly News, February 5 to 11, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi and Michel Bouvier.
- 📰 GPCR Weekly News, April 10 to 16, 2023
Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering Elk Kossatz, Michel Bouvier, Jana Selent, et al. for their study on G protein-specific mechanisms in the serotonin 5-HT2A
- 📰 GPCR Weekly News, February 12 to 18, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, and Michel Bouvier.
- 📰 GPCR Weekly News, January 22 to 28, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, and Michel Bouvier We will also have a poster
- 📰 GPCR Weekly News, December 18 to 31, 2023
Franziska M Heydenreich, Michel Bouvier, Brian Kobilka, M Madan Babu, and their team's work on Molecular
- 📰 GPCR Weekly News, June 17 to 23, 2024
Shane Wright, Michel Bouvier, et al., for their work on Conformation- and activation-based BRET sensors
- 📰 GPCR Weekly News, February 19 to 25, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, Cesare Orlandi, Simone Prömel and Michel Bouvier
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Franziska Heydenreich, Sudarshan Rajagopal, Graham Ladds, and Michel Bouvier.
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
K., Bouvier, M., & Babu, M. M. (2023).
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Bouvier, M., Oligomerization of G-protein-coupled transmitter receptors.
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
K., Bouvier, M., & Babu, M. M. (2023).
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Michel, B. Y.; Burger, A. -L.; Bourrier, E.; Ayoub, M. M.; Roux, T.; Cottet, M.; Durroux, T.; Douzon, S.; Bdioui, S.; Gregor, N.; Bourrier, E.; Oueslati, N.
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
eLife. 2024 Nov 8; 13:RP97033. doi: 10.7554/eLife.97033.3 Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier
- Dr. GPCR University registration is now open! Secure your spot now!
and ligand bias of G protein-coupled receptors Antonios Drakopoulos, Peter Gmeiner, Davide Calebiro, Michael
- Unlocking the Future of Medicine: Advancements in GPCR Research
et al. for their work on Conformational dynamics underlying atypical chemokine receptor 3 activation Michael
- 📰 GPCR Weekly News, January 1 to 7, 2024
Congratulations to Domain Therapeutics for appointing Michael Gottlieb as Chairman and Dr.
